BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18712601)

  • 1. Midkine mRNA is overexpressed in pancreatic cancer.
    Ohhashi S; Ohuchida K; Mizumoto K; Egami T; Yu J; Cui L; Toma H; Takahata S; Nabae T; Tanaka M
    Dig Dis Sci; 2009 Apr; 54(4):811-5. PubMed ID: 18712601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice.
    Ohuchida K; Mizumoto K; Ohhashi S; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Int J Cancer; 2007 Apr; 120(8):1634-40. PubMed ID: 17236203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm.
    Morimatsu K; Aishima S; Yamamoto H; Hayashi A; Nakata K; Oda Y; Shindo K; Fujino M; Tanaka M; Oda Y
    Hum Pathol; 2013 Sep; 44(9):1714-21. PubMed ID: 23597774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of mesothelin mRNA in pure pancreatic juice from patients with pancreatic carcinoma, intraductal papillary mucinous neoplasm of the pancreas, and chronic pancreatitis.
    Watanabe H; Okada G; Ohtsubo K; Yamaguchi Y; Mouri H; Motoo Y; Wakabayashi T; Sawabu N
    Pancreas; 2005 May; 30(4):349-54. PubMed ID: 15841046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.
    Ohuchida K; Mizumoto K; Fujita H; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2006 Sep; 210(1):42-8. PubMed ID: 16794990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of midkine in pancreatic duct adenocarcinomas induced by N-Nitrosobis(2-oxopropyl)amine in hamsters and their cell lines.
    Tsutsumi M; Kadomatsu K; Tsujiuchi T; Sakitani H; Ikematsu S; Kubozoe T; Yoshimoto M; Muramatsu T; Sakuma S; Konishi Y
    Jpn J Cancer Res; 2000 Oct; 91(10):979-86. PubMed ID: 11050467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LIM only 4 is overexpressed in late stage pancreas cancer.
    Yu J; Ohuchida K; Nakata K; Mizumoto K; Cui L; Fujita H; Yamaguchi H; Egami T; Kitada H; Tanaka M
    Mol Cancer; 2008 Dec; 7():93. PubMed ID: 19099607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and differential diagnosis of intraductal papillary mucinous neoplasm of pancreas].
    Ji Y; Tan YS; Zhu XZ; Zeng HY; Kuang TT; Jin DY
    Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):77-81. PubMed ID: 16630480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of indicator genes using global complementary DNA (cDNA) amplification, by polyadenylic acid reverse transcriptase polymerase chain reaction (poly A RT-PCR): A feasibility study using paired samples from tissue and ductal juice in patients undergoing pancreatoduodenectomy.
    Sanyal S; Siriwardena AK; Byers R
    Pancreatology; 2018 Jun; 18(4):458-462. PubMed ID: 29574096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A11, a putative tumor suppressor gene, is overexpressed in pancreatic carcinogenesis.
    Ohuchida K; Mizumoto K; Ohhashi S; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Clin Cancer Res; 2006 Sep; 12(18):5417-22. PubMed ID: 17000675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midkine promotes perineural invasion in human pancreatic cancer.
    Yao J; Li WY; Li SG; Feng XS; Gao SG
    World J Gastroenterol; 2014 Mar; 20(11):3018-24. PubMed ID: 24659893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
    Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of GRP94 expression promotes apoptosis in pancreatic cancer cells.
    Pan Z; Erkan M; Streit S; Friess H; Kleeff J
    Int J Oncol; 2009 Oct; 35(4):823-8. PubMed ID: 19724918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of pancreatic juice proteins as biomarkers of pancreatic cancer.
    Gao J; Zhu F; Lv S; Li Z; Ling Z; Gong Y; Jie C; Ma L
    Oncol Rep; 2010 Jun; 23(6):1683-92. PubMed ID: 20428826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100P is an early developmental marker of pancreatic carcinogenesis.
    Ohuchida K; Mizumoto K; Egami T; Yamaguchi H; Fujii K; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Clin Cancer Res; 2006 Sep; 12(18):5411-6. PubMed ID: 17000674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs for Detection of Pancreatic Neoplasia: Biomarker Discovery by Next-generation Sequencing and Validation in 2 Independent Cohorts.
    Vila-Navarro E; Vila-Casadesús M; Moreira L; Duran-Sanchon S; Sinha R; Ginés À; Fernández-Esparrach G; Miquel R; Cuatrecasas M; Castells A; Lozano JJ; Gironella M
    Ann Surg; 2017 Jun; 265(6):1226-1234. PubMed ID: 27232245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midkine as a prognostic biomarker in oral squamous cell carcinoma.
    Ota K; Fujimori H; Ueda M; Shiniriki S; Kudo M; Jono H; Fukuyoshi Y; Yamamoto Y; Sugiuchi H; Iwase H; Shinohara M; Ando Y
    Br J Cancer; 2008 Aug; 99(4):655-62. PubMed ID: 18682710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas.
    Yantiss RK; Woda BA; Fanger GR; Kalos M; Whalen GF; Tada H; Andersen DK; Rock KL; Dresser K
    Am J Surg Pathol; 2005 Feb; 29(2):188-95. PubMed ID: 15644775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Sonic hedgehog signaling pathway correlates with the tumorigenesis of intraductal papillary mucinous neoplasm of the pancreas.
    Satoh K; Kanno A; Hamada S; Hirota M; Umino J; Masamune A; Egawa S; Motoi F; Unno M; Shimosegawa T
    Oncol Rep; 2008 May; 19(5):1185-90. PubMed ID: 18425375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A4 mRNA is a diagnostic and prognostic marker in pancreatic carcinoma.
    Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Fujita H; Nakata K; Ueda J; Sato N; Nagai E; Tanaka M
    J Gastrointest Surg; 2009 Oct; 13(10):1852-8. PubMed ID: 19653048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.